Detalles de la búsqueda
1.
[Clinical analysis of 500 cases of hematological diseases with oral presentation as the first manifestation].
Shanghai Kou Qiang Yi Xue
; 29(6): 638-641, 2020 Dec.
Artículo
en Zh
| MEDLINE | ID: mdl-33778833
2.
Once-Weekly 1.6 mg/m2 Bortezomib BCD Regimen in Elderly Patients with Newly Diagnosed Multiple Myeloma Who are Unfit for Standard Dose Chemotherapy.
Indian J Hematol Blood Transfus
; 33(1): 22-30, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28194052
3.
Retrospective Study of Pegaspargase, Gemicitabine, Oxaliplatin and Dexamethasone (Peg-GemOD) as a First-Line Therapy for Advanced-Stage Extranodal NK/T Cell Lymphoma.
Indian J Hematol Blood Transfus
; 33(1): 74-81, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28194060
4.
[Clinical study on fludarabine combined with cytarabine regimen in the treatment of patients with refractory and relapsed acute myeloid leukemia].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 17(3): 774-6, 2009 Jun.
Artículo
en Zh
| MEDLINE | ID: mdl-19549406
5.
[Progress of study on survivin in diffuse large B-cell lymphoma--review].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 16(6): 1487-90, 2008 Dec.
Artículo
en Zh
| MEDLINE | ID: mdl-19099670
6.
[Correlation of cell cycle alteration to SOCS-1 gene demethylation induced by arsenic trioxide in myeloma cell lines].
Ai Zheng
; 27(11): 1150-4, 2008 Nov.
Artículo
en Zh
| MEDLINE | ID: mdl-19000444
7.
[Arsenic trioxide induces socs-1 gene demethylation in myeloma cell lines].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 16(5): 1064-8, 2008 Oct.
Artículo
en Zh
| MEDLINE | ID: mdl-18928596
Resultados
1 -
7
de 7
1
Próxima >
>>